Serkan Yaraş et al. 2019. Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey. Turkish Journal of Gastroenterology. 30, 4 (Jul. 2019), 331–335.